
|Videos|May 5, 2017
Which Rx-to-OTC Switches Could Be on the Horizon?
Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.
Advertisement
Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
4
Advancing Precision Oncology: Pharmacist Perspectives on MRD Testing and Diagnostic Innovation
5

















































































































































































































